X-11298573-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_001142.2(AMELX):āc.170T>Cā(p.Met57Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000273 in 1,098,232 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 23)
Exomes š: 0.0000027 ( 0 hom. 0 hem. )
Consequence
AMELX
NM_001142.2 missense
NM_001142.2 missense
Scores
8
7
2
Clinical Significance
Conservation
PhyloP100: 3.63
Genes affected
AMELX (HGNC:461): (amelogenin X-linked) This gene encodes a member of the amelogenin family of extracellular matrix proteins. Amelogenins are involved in biomineralization during tooth enamel development. Mutations in this gene cause X-linked amelogenesis imperfecta. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
ARHGAP6 (HGNC:676): (Rho GTPase activating protein 6) This gene encodes a member of the rhoGAP family of proteins which play a role in the regulation of actin polymerization at the plasma membrane during several cellular processes. This protein is thought to have two independent functions, one as a GTPase-activating protein with specificity for RhoA, and another as a cytoskeletal protein that promotes actin remodeling. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.909
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMELX | NM_001142.2 | c.170T>C | p.Met57Thr | missense_variant | 5/6 | ENST00000380714.7 | NP_001133.1 | |
ARHGAP6 | NM_013427.3 | c.589-43866A>G | intron_variant | ENST00000337414.9 | NP_038286.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMELX | ENST00000380714.7 | c.170T>C | p.Met57Thr | missense_variant | 5/6 | 1 | NM_001142.2 | ENSP00000370090.3 | ||
ARHGAP6 | ENST00000337414.9 | c.589-43866A>G | intron_variant | 1 | NM_013427.3 | ENSP00000338967.4 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183419Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67845
GnomAD3 exomes
AF:
AC:
1
AN:
183419
Hom.:
AF XY:
AC XY:
0
AN XY:
67845
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000273 AC: 3AN: 1098232Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 363590
GnomAD4 exome
AF:
AC:
3
AN:
1098232
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
363590
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 02, 2022 | The c.212T>C (p.M71T) alteration is located in exon 6 (coding exon 5) of the AMELX gene. This alteration results from a T to C substitution at nucleotide position 212, causing the methionine (M) at amino acid position 71 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Pathogenic
.;D;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
.;M;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;N;N
REVEL
Pathogenic
Sift
Uncertain
D;D;T
Sift4G
Uncertain
D;T;T
Polyphen
D;D;D
Vest4
MutPred
0.61
.;Gain of relative solvent accessibility (P = 0.005);.;
MVP
MPC
0.81
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at